FORMA THERAPEUTICS HOLDINGS (FMTX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:FMTX • US34633R1041

20.01 USD
+0.03 (+0.15%)
At close: Oct 13, 2022
20.01 USD
0 (0%)
After Hours: 10/13/2022, 8:24:26 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FMTX. FMTX was compared to 524 industry peers in the Biotechnology industry. While FMTX seems to be doing ok healthwise, there are quite some concerns on its profitability. FMTX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • FMTX had negative earnings in the past year.
FMTX Yearly Net Income VS EBIT VS OCF VS FCFFMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -50M -100M -150M

1.2 Ratios

Industry RankSector Rank
ROA -40.02%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FMTX Yearly ROA, ROE, ROICFMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 20 -20

1.3 Margins

  • FMTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FMTX Yearly Profit, Operating, Gross MarginsFMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 -10 -20 -30

More info and screens

6

2. Health

2.1 Basic Checks

  • FMTX has more shares outstanding than it did 1 year ago.
  • FMTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FMTX Yearly Shares OutstandingFMTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M 40M
FMTX Yearly Total Debt VS Total AssetsFMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 8.17 indicates that FMTX is not in any danger for bankruptcy at the moment.
  • FMTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.17
ROIC/WACCN/A
WACCN/A
FMTX Yearly LT Debt VS Equity VS FCFFMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 12.74 indicates that FMTX has no problem at all paying its short term obligations.
  • FMTX has a Quick Ratio of 12.74. This indicates that FMTX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 12.74
Quick Ratio 12.74
FMTX Yearly Current Assets VS Current LiabilitesFMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M

More info and screens

0

3. Growth

3.1 Past

  • FMTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.01%.
EPS 1Y (TTM)-32.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • FMTX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.50% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.37%
EPS Next 2Y-1.79%
EPS Next 3Y0.88%
EPS Next 5Y-2.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FMTX Yearly Revenue VS EstimatesFMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2022 2023 2024 2025 2026 50M 100M 150M
FMTX Yearly EPS VS EstimatesFMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • FMTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FMTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FMTX Price Earnings VS Forward Price EarningsFMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.98
FMTX Per share dataFMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.79%
EPS Next 3Y0.88%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for FMTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORMA THERAPEUTICS HOLDINGS / FMTX FAQ

Can you provide the ChartMill fundamental rating for FORMA THERAPEUTICS HOLDINGS?

ChartMill assigns a fundamental rating of 2 / 10 to FMTX.


What is the valuation status of FORMA THERAPEUTICS HOLDINGS (FMTX) stock?

ChartMill assigns a valuation rating of 1 / 10 to FORMA THERAPEUTICS HOLDINGS (FMTX). This can be considered as Overvalued.


What is the profitability of FMTX stock?

FORMA THERAPEUTICS HOLDINGS (FMTX) has a profitability rating of 1 / 10.


Is the dividend of FORMA THERAPEUTICS HOLDINGS sustainable?

The dividend rating of FORMA THERAPEUTICS HOLDINGS (FMTX) is 0 / 10 and the dividend payout ratio is 0%.